Similarly, airway epithelial cells from patients with asthma and COPD have higher expression levels of MUC5AC than those from healthy individuals (49–51), so screens to identify compounds to reduce goblet cell metaplasia or mucous hypersecretion would also be feasible in disease contexts. The gene discussed is MUC5AC; the disease is asthma.